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Introduction
The insect vector borne protozoan parasites of the family Kinetoplastidae cause a range of human diseases, including the leishmaniases and African Sleeping Sickness. These infections are of increasing prevalence, particularly in developing countries, and have been classified by the World Health Organisation as Category I emerging or uncontrolled diseases (Remme, et al. 2002) . For example, the Leishmania spp. (the causative agents of the leishmaniases) infect more than 12 million people in five continents and are endemic in 88 nation states putting over 350 million people at risk, with instances of leishmaniasis not uncommon in certain regions of North America and southern Europe. Moreover, the spread and severity of disease is exacerbated by its status as an important co-infection in AIDS patients and the overlap in prevalence of HIV and Leishmania (Alvar, et al. 2008 ). In the absence of effective vaccines, the treatment of kinetoplastid infections is difficult with the most serious visceral form of leishmaniasis often requiring a long, costly course of drug therapy. In addition, available drugs often exhibit serious side-effects and resistance is rapidly emerging (Remme, et al. 2002) . These facts make the discovery and validation of new therapeutic agents a priority.
The diverse, amphipathic sphingolipids consist of a sphingoside backbone with long-chain base and polar alcohol attachments. These essential lipid species are found in all eukaryotic cells, as well as in some prokaryotic organisms and viruses (Smith and Merrill 2002) . In eukaryotes, the unmodified sphingolipid, ceramide, is a precursor for the synthesis of complex sphingolipids in the Golgi apparatus. The resultant lipid species are subsequently concentrated in the outer leaflet of the plasma membrane. Here, together with sterols, they form the microdomains known as lipid rafts (Futerman and Hannun 2004) . Such domains have been suggested to be central to a wide array of cellular processes, including the formation of signal transduction complexes (Magee, et al. 2002; Pierce 2002 ) and the polarized trafficking of lipid-modified proteins (Brown and London 1998) . Importantly, sphingolipid metabolites such as ceramide and phosphorylated sphingosine (sphingosine-1-phosphate), are also involved in the intracellular signal transduction processes that regulate cell growth, differentiation and programmed cell death (apoptosis) (Futerman and Hannun 2004) .
Sphingolipids demonstrate structural divergence in evolution. Whilst sphingomyelin (SM) is the predominant phosphosphingolipid (PSL) of mammalian cells, inositol phosphorylceramide (IPC) is found in the fungi, plants and some protozoa but not in 4 mammals (Lester and Dickson 1993; Sperling and Heinz 2003) . SM is formed by the transfer of the phosphorylcholine head group from the phospholipid phosphatidylcholine (PC) to ceramide, a reaction catalyzed by SM synthase (Huitema, et al. 2004 ). The related enzyme, IPC synthase, mediates the formation of IPC in fungi, plants and the pathogenic kinetoplastid protozoa (e.g. Leishmania spp.) by catalyzing the transfer of phosphorylinositol from phosphatidylinositol (PI) to ceramide or phytoceramide (Becker and Lester 1980; Bromley, et al. 2003; Denny, et al. 2006 ). In the fungi this enzyme activity has been attributed to the AUR1p protein first identified in Saccharomyces cerevisiae and subsequently in several fungal pathogens (Heidler and Radding 1995; Heidler and Radding 2000) . We have isolated a functional orthologue of this protein in the kinetoplastid, protozoan parasite Leishmania major (LmjIPCS) (Denny, et al. 2006) .
LmjIPCS is encoded by a single gene (GeneDB, LmjF35.4990) , and closely related orthologues are found in the complete genome sequences of the related kinetoplastid pathogens, Trypanosoma brucei (the causative agent of African Sleeping Sickness) and T. cruzi (Chagas Disease) (Denny, et al. 2006) . IPC synthase activity is evident in both the insect and mammalian stages of the L. major lifecycle, however in the intra-macrophage form the parasite is predicted to scavenge host cell ceramide for use as substrate by LmjIPCS (Zhang, et al. 2005; Zhang, et al. 2009 ).
As an essential activity with no mammalian equivalent the fungal IPC synthase has become a recognized and well studied drug target (Georgopapadakou 2000; ). The discovery of functional orthologues in the kinetoplastid pathogenic protozoa has led to its further consideration as an anti-protozoal target (Suzuki, et al. 2008) . It is known that LmjIPCS activity is susceptible to the established fungal inhibitor aureobasidin A (Denny, et al. 2006 ). In addition, this compound has been demonstrated to inhibit the growth and infectivity of L. amazonensis (Tanaka, et al. 2007 ). Furthermore, recent work in our laboratory (Mina, et al. 2009 ) and elsewhere (Sutterwala, et al. 2008 ) has both genetically and pharmacologically validated the kinetoplastid enzyme as a target in T.
brucei. Therefore, further study of the LmjIPCS (and other kinetoplastid orthologues) is vital in moving towards the ultimate goal of identifying compounds with the potential for development into much needed, pharmacologically active anti-protozoals. Herein we report the establishment of a robust 96-well plate based assay system that uses easily obtainable, transgenic yeast-derived material, together with its application to detail the kinetic parameters of LmjIPCS and demonstrate the inhibitory effects of several substrate analogues.
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Materials and Methods
Materials
Phosphatidylinositol (bovine liver PI; predominant species 1-stearoyl-2-arachidonoyl-snglycero-3-phospho-1'-myo-inositol sodium salt) was from Avanti Polar Lipids. D-erythrosphingosine (d18:1; sphing-4-enine, (2S,3R,E)-2-aminooctadec-4-ene-1,3-diol) and Nacetyl-D-erythro sphingosine (d18:1/2:0; N-acetyl-sphing-4-enine, (2S,3R,4E)-N-acetyl-2-aminooctadec-4-ene-1,3-diol) were from TOCRIS BioScience. C 18 -Ceramide (d18:1/18:0; -stearoyl-2-aminooctadec-4-ene-1,3-diol) and diacylglycerol (1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol) were
Preparation of LmjIPCS microsomal material
Auxotrophic AUR1 mutant Saccharomyces cerevisiae was complemented by the expression of the L. major IPC synthase to create YPH499-HIS-GAL-AUR1 pRS246
LmjIPCS (Denny, et al. 2006 ). These cells were propagated in SD medium (0.17% Bacto yeast nitrogen base, 0.5% ammonium sulphate and 2% dextrose) containing the appropriate nutritional supplements, and microsomes prepared from an exponentially growing culture (Fischl et al., 2000) . (Fischl et al., 2000) . The conversion of the fluorescent acceptor substrate NBD-C 6 -ceramide to the product NBD-C 6 -IPC was measured and quantified with respect to known concentrations of NBD-C 6 -ceramide, activity calculated as U.µl -1 and the samples were stored at -80 °C until use. Enzyme turnover was calculated per milligrams of total protein in the sample (U.mg -1 ).
Thin layer chromatography (TLC) based LmjIPCS synthase assay
Both unwashed and CHAPS-washed (1 µg) microsomal membranes were used in a 50 µl assay mix containing 1 mM PI, 100 mM Tris HCl (pH7.4) and 200 µM NBD-C 6 -ceramide (Figueiredo et al., 2005) . The reaction was pre-incubated before the addition of the NBD-C 6 -ceramide at 30 °C (the established optimum temperature in the assay) for 30 minutes and subsequently for a further hour before quenching with 150 µl of chloroform:methanol:water (10:10:3). After biphasic separation the organic layer was removed, dried in a rotavapor (Eppendorf Concentrator 5301) and re-suspended in 20 µl of 10:10:3. The reaction products were fractionated using HPTLC silica plates (Merck) and the eluent system chloroform:methanol:aqueous 0.25% KCl (55:45:10). The R f values for the substrate, NBD-C 6 -ceramide, and the product, NBD-C 6 -IPC were 0.96 and 0.57 respectively. Quantification was carried out using a FLA3000 scanner (Fujifilm) and AIDA Image Analyzer ® software (version 3.52).
96-well plate-based LmjIPCS synthase assay for kinetic analyses
CHAPS-washed membranes (Aeed, et al. 2004 ), 0.6 U or as described, were used in a reaction mix containing 100 µM (or as indicated) PI, 50 mM KH 2 PO 4 (pH7.0) and 5 µM (or as indicated) NBD-C 6 -ceramide. Following pre-incubation at 30°C for 30 minutes, the reaction was initiated by the addition of the NBD-C 6 -ceramide (5 µM or as indicated) and 2.4 mM CHAPS. The reaction was incubated for the specified period of time and subsequently quenched by the addition of 200 µl of methanol. Separation of the reaction product, NBD-C 6 -IPC, from the substrate NBD-C 6 -ceramide was achieved by applying the 7 reaction mix to 100 µl (sedimented gel volume) of AG4-X4 resin (BioRad), formate form, in 96-well Multiscreen  Solvinert filter plates (Millipore) using a vacuum manifold (Millipore).
The resin was washed 5 times with 200 µl methanol, the product was eluted into
OptiPlate 96 Substrate analogues were employed in inhibition studies and added with the fluorescent substrate NBD-C 6 -ceramide in the quantities indicated.
The assay system was validated as excellent for screening purposes with a Z' value of 0.58 (Zhang, et al. 1999 ). Calculation of this value utilized 2 bespoke inhibitors, (4E) N-
(phenylacetyl)-1-deoxy-sphing-4-enine and (2R,4E) N-phenylacetyl2-aminooctadec-4-en-
1-ol whose synthesis and screening will be subsequently reported.
Mass spectrometry
Analyses were performed on an LTQFT (ThermoFinnigan Corp); an FTICR MS instrument equipped with a 7.0 T magnet. Chloroform extracts were introduced into the electrospray ion source by direct infusion from a syringe at a flow rate of 3 µl.min -1 . Positive ion measurements were made with the source voltage at 4.0 kV and negative ion measurements were made with the source voltage at 3.5 kV. The tube lens was kept at 100 V and the source temperature at 275 °C for all experiments.
Cytotoxicity screening
L. major (MHOM/IL/81/Friedlin) and L. mexicana (MNYC/BZ/62/M379) parasites were maintained at 26 °C in Schneider's Drosophila media (Sigma Aldrich) supplemented with heat inactivated foetal bovine sera (15% for promastigotes and 20% for amastigotes; Biosera). L. mexicana promastigotes were transformed into axenic amastigotes by a pH and temperature shift as previously described (Bates, 1994) . In 96-well plates (Nunc)
parasites at 10 5 ml -1 were incubated with compounds in triplicate (including miltefosine (Cayman Chemical) as a positive control, and untreated parasites and media as negative controls) for 24 hours before incubation with Alamar Blue (Invitrogen) for 4 hours prior to assessing cell viability using a fluorescent plate reader (Biotek; 560EX nm/600EM nm).
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LD 50 was calculated after plotting cell viability (as % of untreated control) against log compound concentration (µM).
Results and Discussion
Assay of LmjIPCS microsomal material
The high levels of endogenous PI present in yeast microsomes (Aeed, et al. 2004) rendered establishing the kinetic parameters of LmjIPCS with respect to this donor substrate problematic. Initial assay experiments using unrefined material derived from
LmjIPCS complemented HIS-GAL-AUR1 auxotrophic yeast IPCS mutants (Denny, et al. 2006 ) demonstrated that endogenous, microsomal PI accounted for approximately 25% of the measured LmjIPCS turnover (figure 2A), making accurate determination of the enzyme kinetic parameters impossible. A similar problem has previously been identified with the use of Trypanosoma cruzi derived microsomes in an assay of TcIPCS turnover (Figueiredo, et al. 2005 ) . However, it has been demonstrated that washing microsomal membranes derived from the pathogenic yeast, Candida albicans with a zwitterionic detergent (CHAPS) removed endogenous substrate lipids without affecting IPCS activity (Aeed, et al. 2004) . Adopting this approach and employing microsomes from LmjIPCS complemented HIS-GAL-AUR1 yeast, washed with CHAPS as described, the parasite enzyme assay proved to be dependent not only on the addition of the fluorescent acceptor substrate, NBD-C 6 -ceramide, but now also more than 90% dependent on the addition of the donor substrate (bovine liver PI; figure 2A ). It has previously been demonstrated that the S. cerevisiae orthologous enzyme, AUR1p, is unable to utilise bovine liver PI (Mina, et al. 2009 ). In the present assay system, the CHAPS-washed microsomes also demonstrated an approximately 2-fold higher level of enzyme turnover than equivalent quantities of crude material ( figure 2B ). This increase is most likely due to enrichment of the sample for LmjIPCS as other proteins are washed away from the detergent insoluble material. However, the removal of microsomal proteins and lipids may also reduce the spatial volume of the washed material leading to more rapid diffusion of applied exogenous substrates into the membranes. Taken together these data indicate that washing the microsomes with CHAPS depletes them of PI, and perhaps (phyto)ceramide, thereby facilitating more accurate determination of the kinetics of LmjIPCS. Moreover, the fact that LmjIPCS remained highly active within a detergent resistant lipid environment suggests that the enzyme may reside within CHAPS-resistant lipid microdomains in vivo (Rouvinski, et al. 2003) .
10
Determination of LmjIPCS assay parameters
Using the 96-well plate formatted system described, reproducible, quantitative kinetic data could be obtained for the enzyme from CHAPS-washed LmjIPCS yeast microsomes. In the first instance the formation of product (IPC) over time was determined. The results demonstrated that the reaction rate is linear for 30 minutes before it decreases over time ( figure 3A) . As a consequence all subsequent assays were performed with a 15 minute reaction time to ensure linearity under the specified conditions, turnover was assumed to be equivalent to initial velocity (v 0 ).
Since both substrates are in excess and only approximately 12 % of the limiting acceptor substrate, NBD-C 6 -ceramide, is consumed after 1 hour, the reasons for the decrease in reaction rate above 30 minutes are unclear. The IPC product may be localised around the enzyme affecting a change in the diffusion rate of the substrates to the active site. It is also possible that LmjIPCS activity is modulated by inhibitory feedback from the synthesized NBD-C 6 -IPC or diacylglycerol (DAG) which is formed as a by-product of IPC synthase turnover (Denny, et al. 2006) . Analysis of the inhibitory affect of DAG indicated a logIC 50 value of 0.92±0.8 and an IC 50 of 8.3 µM (figure 3B) supporting the latter hypothesis.
Product (NBD-C 6 -IPC) formation also increased in a linear manner with increasing enzyme concentration up to 0.8 U/assay ( figure 3C ). However, the linear relationship deviated beyond this point (data not shown). Notably, increasing the concentration of enzyme also leads to a change in the protein : lipid : detergent (CHAPS) ratio and hence modulates the substrate concentration at the active site of LmIPCS. Taking this observation into account 0.6 U of LmIPCS (within the linear range) was employed in all subsequent analyses.
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Determination of LmjIPCS kinetic parameters
Having established a standardized set of conditions that gave a linear response, and in which endogenous interfering substrate was minimized by detergent washing, the kinetic parameters of LmjIPCS with respect to both the acceptor (NBD-C 6 -ceramide) and donor (PI) substrates were determined. Initially, the data obtained were tested against the Michaelis-Menten model and with respect to increasing concentrations of NBD-C 6 -ceramide gave a curve of good fit (R 2 = 0.97; figure 4A ). The apparent K m for the acceptor substrate was 3.5±0.35 µM and the apparent V max 2.1±0.07 pmol.min −1 .U −1 . However, determination of the Hill constant revealed a Hill slope of 2.7 that indicated co-operative binding of substrates was occurring (Hill 1910) .
In contrast, with [NBD-C 6 -ceramide] fixed at 5 µM, the data with respect to the PI showed a poor fit to the Michaelis-Menten equation (R 2 = 0.82; figure 4B ), with considerable deviation at high concentrations of donor substrate. The enzyme orthologue from the pathogenic yeast C. albicans has previously been shown to behave in a similar manner, a phenomenon which was described as being caused by substrate inhibition (Aeed, et al. 2004) . However, at a higher, saturating concentration of the acceptor substrate, [NBD-C 6 -ceramide] = 20 µM (> 5x apparent K m ), no apparent inhibition at high [PI] could be detected ( figure 4C ). This strongly suggested that activity is dependent on the substrate molar ratio, with a dilution effect being observed with low NBD-C 6 -ceramide (5 µM) and high PI (>150 µM). The % molar concentration of NBD-C 6 -ceramide dropped 30% from 0.82% at 12.5 µM PI and 600 µM CHAPS to 0.58% 250 µM PI and 600 µM CHAPS. In contrast a change in concentration of the acceptor substrate has little affect on the % molar concentration of PI (14.3% at 1 µM NBD-C 6 -ceramide and 600 µM CHAPS to 13.9% 20 µM NBD-C 6 -ceramide NBD-C 6 -ceramide and 600 µM CHAPS) and CHAPS concentration.
PI vesicles can be solubilised by CHAPS far below the CMC of this detergent at 0.27 mM
c : critical concentration of free detergent; Schürholz 1996) . Therefore under the experimental conditions employed (0.6mM CHAPS) in the assay system PI/CHAPS mixed micelles are formed. The molar detergent to lipid ration of these micelles (R c ) is 0.17, meaning that CHAPS is a minor component, approximately 15% of the total molar concentration in micelles (Schürholz 1996) . Based on these data the [D w ] c in the assay system employed can be calculated using Equation 1 (Schürholz 1996) .
12
Equation 1
At expressed as mol% in PI/CHAPS micelles; Deems, et al. 1975) , resulted in nonconvergent results. However, given that LmjIPCS is an integral membrane protein within microsomal membranes the enzyme can fuse with PI/CHAPS micelles, or maintain its integrity and bounce between micelles whilst interacting with the bulk monomeric CHAPS/NBD-C 6 -ceramide in the assay buffer. Both cases would confer bulk concentration dependence to the kinetics (Carman, et al. 1995) .
Lineweaver-Burk analyses of the data set gave a near parallel pattern (figure 5A 
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Equation 2
Notably, the relatively high affinity of the acceptor substrate for LmjIPCS compared with that of the donor PI was consistent with the proposal that ceramide, a highly bioactive molecule, is the rate-limiting substrate in the in situ IPC synthase reaction. In contrast PI is a relatively abundant substrate in most membraneous environments (Aeed, et al. 2004; Dickson 1998; Leber, et al. 1995) .
Based on these data the value Ø AB was assumed to be zero thereby reducing Equation 2 to that describing double displacement kinetics (Equation 3). Details of the factors of Ø 0 , Ø A , Ø B is detailed in supplementary data (S1).
Equation 3
These analyses provide strong support for the notion that LmjIPCS functions via a double displacement model. This is further evidenced by the close correlation of experimental data with simulations derived from Equation 3 ( figure 5C and D).
With this in mind, the apparent fit to the Michaelis-Menton model with respect to ceramide initially observed was most likely due to pre-incubation with saturating levels of PI leaving the majority of the enzyme in an intermediate phosphorylated state. In this state it is predicted that LmjIPCS has mediated the transfer of the phosphorylinositol group of PI to the reactive histidine within the identified catalytic triad (Denny, et al. 2006 ) with the concomitant release of DAG. Notably mutation of His-294 within the yeast AUR1p triad has been shown to result in non-viable haploid cells (Levine, et al. 2000) and the equivalent mutation (His-264) in LmjIPCS rendered it unable to complement auxotrophic AUR1p mutant yeast (Mina and Denny, unpublished) . The second step in the reaction is then initiated by the addition of acceptor substrate (ceramide) when the phosphorylated intermediate is subjected to nucleophilic attack by the oxygen of the ceramide hydroxyl group, resulting in phosphoryl group transfer to the sphingoid base thus forming IPC.
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Substrate analogues as competitive inhibitors
The delineation of the kinetic parameters of LmjIPCS also provided the opportunity to begin to further understand the mode of action of this enzyme and perhaps, via a rational approach, to design specific inhibitors. Given the high affinity of the acceptor substrate for analogue has previously been shown to act as a substrate for the yeast enzyme . Conversely, no IP-D-erythro-sphingosine could be detected in the MS spectra either in positive or negative ion mode, which indicated that D-erythro-sphingosine is not a substrate for LmjIPCS, rather it is acting as a true inhibitor (data not shown 
LmjIPCS
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In structure-function terms these data indicated that the free-amino group present in Derythro-sphingosine abolishes enzyme activity, whilst masking this group with even a minimal acyl moiety (N-acetyl-D-erythro-sphingosine) restored it. Similarly, sphingosine analogues have demonstrated an inhibitory effort on the S. cerevisiae phosphatidate phosphatase (Wu, et al. 1993) , a member of the LPP enzyme superfamily which are believed to share a mechanism of action with the sphingolipid synthases (Huitema, et al. 2004 ). Taken together it may be hypothesized that the protonated free-amino group of Derythro-sphingosine electrostatically interferes with the active site of these enzymes, an observation which may potentially be exploited in the rational design of specific enzyme inhibitors.
Summary
Using the multi-well format assay established in this work we have deduced the kinetic parameters of LmjIPCS with respect to both the donor (PI) and acceptor (NBD-C 6 -ceramide) substrates, and provided evidence that the enzyme functions through a bi-bi (ping-pong) substrate kinetic model. These data provide the first direct indication of the mechanism of action of the sphingolipid synthase family. Such analyses would not have been possible using a conventional assay system such as that previously employed for the T. cruzi orthologue (Figueiredo, et al. 2005) . However, by employing a complemented yeast system, large quantities of active LmjIPCS could be isolated in a cost effective manner avoiding the handling of pathogenic material. Furthermore washing the microsomal starting material with CHAPS removed endogenous, contaminating donor substrate (PI) leaving an environment in which the enzyme exhibited not only a dependency on exogenous PI, but also a higher level of specific activity.
With a Z' value of 0.58 (Zhang, et al. 1999 ), the assay system described lends itself to high-throughput screening for inhibitors of a protozoal enzyme activity that has been demonstrated to be essential for kinetoplastid pathogens (Mina, et al. 2009; Sutterwala, et al. 2008) . The assay of ceramide analogues demonstrated this potential and provides the backbone for consideration of rationally designed enzyme inhibitors. In the longer term, it is hoped that it will assist in the discovery of new, much needed therapies for leishmaniasis and African sleeping sickness. 
